Redhill Biopharma (RDHL) vs XTL Biopharmaceuticals (XTLB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
XTL Biopharmaceuticals is the larger company by market cap ($4.8 million vs $4.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | RDHL | XTLB |
|---|---|---|
| Share price | $0.5131 | $1.97 |
| Market cap | $4.56M | $4.84M |
| 1-day change | +8.25% | -0.51% |
| Forward P/E | 17.10 | — |
| EPS (TTM) | $0.00 | $-0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.14 | $7.44 |
| 52-week low | $0.4351 | $1.97 |
| Distance from 52-week high | -76.02% | -73.52% |
| Average volume | 1.81M | 8.49K |
| Shares outstanding | 8.89M | 2.46M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
RDHL vs XTLB FAQ
Which is bigger, Redhill Biopharma or XTL Biopharmaceuticals?
XTL Biopharmaceuticals (XTLB) is larger, with a market capitalization of $4.84M compared with $4.56M for Redhill Biopharma (RDHL).
Are Redhill Biopharma and XTL Biopharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.